Korean Drug Co. Ltd Net Asset Quality Index
Korean Drug Co. Ltd net asset quality index. Korean Drug Co. Ltd (014570) has a Net Asset Quality Index of 79.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩98.90 Billion minus total liabilities of ₩20.08 Billion yields net assets of ₩78.82 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Korean Drug Co. Ltd (014570) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Korean Drug Co. Ltd (2014–2025)
Net asset quality index of Korean Drug Co. Ltd from 2014 to 2025. This chart shows how Korean Drug Co. Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the index stands at 79.7%, representing net assets of ₩78.82 Billion against total assets of ₩98.90 Billion KRW. Check how strategically is Korean Drug Co. Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Korean Drug Co. Ltd Net Asset Quality Index by Year (2014–2025)
Korean Drug Co. Ltd net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Korean Drug Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Korean Drug Co. Ltd market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.1% | ₩83.07 Billion | ₩94.32 Billion | ₩11.25 Billion | ▲ +0.2 pp |
| 2024 | 87.9% | ₩78.11 Billion | ₩88.89 Billion | ₩10.78 Billion | ▲ +1.9 pp |
| 2023 | 85.9% | ₩77.09 Billion | ₩89.71 Billion | ₩12.62 Billion | ▼ -3.7 pp |
| 2022 | 89.6% | ₩84.71 Billion | ₩94.52 Billion | ₩9.80 Billion | ▲ +3.1 pp |
| 2021 | 86.5% | ₩76.69 Billion | ₩88.61 Billion | ₩11.92 Billion | ▲ +1.5 pp |
| 2020 | 85.0% | ₩70.87 Billion | ₩83.34 Billion | ₩12.47 Billion | ▼ -0.7 pp |
| 2019 | 85.8% | ₩65.05 Billion | ₩75.85 Billion | ₩10.80 Billion | ▼ -0.3 pp |
| 2018 | 86.1% | ₩62.80 Billion | ₩72.96 Billion | ₩10.16 Billion | ▲ +0.8 pp |
| 2017 | 85.3% | ₩56.97 Billion | ₩66.79 Billion | ₩9.82 Billion | ▲ +0.7 pp |
| 2016 | 84.6% | ₩53.66 Billion | ₩63.41 Billion | ₩9.75 Billion | ▲ +0.7 pp |
| 2015 | 83.9% | ₩49.68 Billion | ₩59.20 Billion | ₩9.52 Billion | ▲ +5.4 pp |
| 2014 | 78.5% | ₩48.79 Billion | ₩62.17 Billion | ₩13.38 Billion | — |